Turnstone Biologics Corp.
TSBXDelisted Aug 11, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001764974
Turnstone Biologics Corp. was delisted on Aug 11, 2025; its insiders filed their last Form 4 on Aug 12, 2025; 23 institutions reported holding it in 13F filings for Q2 2025, worth $3.03M in total; no superinvestor held it.
13F holders, Q1 2024
Institutional positions in Turnstone Biologics Corp. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- +4 vs. Q4 2023
- Shares held
- 13.3M
- +329.2K (+2.5%) vs. Q4 2023
- Total value
- $35.0M
- +$1.87M (+5.6%) vs. Q4 2023
- New holders
- 5
- 19 more added
- Sold out
- 1
- 8 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TSBX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 23 | $3.03M |
| Q1 2025 | 23 | $4.26M |
| Q4 2024 | 28 | $5.51M |
| Q3 2024 | 24 | $6.37M |
| Q2 2024 | 47 | $33.3M |
| Q1 2024 | 40 | $35.0M |
| Q4 2023 | 36 | $33.1M |
| Q3 2023 | 35 | $48.0M |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Turnstone Biologics Corp.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nisa Investment Advisors, LLC | 30 | $79 | 0.00% | +30 | New |
| Royal Bank of Canada | 351 | $1.00K | 0.00% | −2,273−86.6% | Reduced |
| Amalgamated Bank | 205 | $1.00K | 0.00% | −909−81.6% | Reduced |
| Avion Wealth | 178 | $1.00K | 0.00% | +178 | New |
| Ameritas Investment Partners, Inc. | 630 | $1.65K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 796 | $2.10K | 0.00% | 00.0% | Unchanged |
| California State Teachers Retirement System | 1,755 | $4.60K | 0.00% | +670+61.8% | Added |
| Citigroup Inc | 2,939 | $7.70K | 0.00% | +1,922+189.0% | Added |
| Tower Research Capital LLC (TRC) | 3,409 | $8.93K | 0.00% | −381−10.1% | Reduced |
| Wells Fargo & Company | 5,013 | $13.1K | 0.00% | +3,126+165.7% | Added |
| JPMorgan Chase & Co | 6,170 | $16.2K | 0.00% | +1,948+46.1% | Added |
| American International Group, Inc. | 7,616 | $20.0K | 0.00% | +4,339+132.4% | Added |
| Rhumbline Advisers | 9,109 | $23.9K | 0.00% | +1,868+25.8% | Added |
| New York State Common Retirement Fund | 18,842 | $49.4K | 0.00% | −25−0.1% | Reduced |
| UBS Group AG | 19,057 | $49.9K | 0.00% | +11,886+165.8% | Added |
| Susquehanna International Group, LLP | 23,371 | $61.2K | 0.00% | +23,371 | New |
| Morgan Stanley | 23,594 | $61.8K | 0.00% | +7,900+50.3% | Added |
| Balyasny Asset Management LLC | 32,746 | $85.8K | 0.00% | +32,746 | New |
| Charles Schwab Investment Management Inc | 34,443 | $90.2K | 0.00% | +19,274+127.1% | Added |
| State Street Corp | 38,491 | $100.8K | 0.00% | +4,642+13.7% | Added |
| Kathleen S. Wright Associates Inc. | 42,553 | $111.5K | 0.05% | +42,553 | New |
| Bridgeway Capital Management, LLC | 59,900 | $156.9K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 99,475 | $260.6K | 0.00% | +34,403+52.9% | Added |
| Barclays PLC | 121,381 | $318.0K | 0.00% | +5,265+4.5% | Added |
| Zimmer Partners, LP | 179,026 | $469.0K | 0.01% | +130,826+271.4% | Added |
| FIL Ltd | 192,657 | $504.8K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 238,084 | $623.8K | 0.00% | +116,148+95.3% | Added |
| Vanguard Group Inc | 369,676 | $968.6K | 0.00% | +73,064+24.6% | Added |
| ExodusPoint Capital Management, LP | 369,780 | $969.0K | 0.01% | +102,927+38.6% | Added |
| Eventide Asset Management, LLC | 458,317 | $1.20M | 0.02% | −250,000−35.3% | Reduced |
| Sectoral Asset Management Inc | 517,648 | $1.36M | 0.53% | 00.0% | Unchanged |
| 72 Investment Holdings, LLC | 549,981 | $1.44M | 2.15% | 00.0% | Unchanged |
| BlackRock Inc. | 663,404 | $1.74M | 0.00% | +361,479+119.7% | Added |
| Citadel Advisors LLC | 684,837 | $1.79M | 0.00% | −3,631−0.5% | Reduced |
| Takeda Pharmaceutical Co Ltd | 895,824 | $2.35M | 0.81% | 00.0% | Unchanged |
| Bank of America Corp | 899,373 | $2.36M | 0.00% | −14,685−1.6% | Reduced |
| PFM Health Sciences, LP | 920,976 | $2.41M | 0.12% | +287,663+45.4% | Added |
| Point72 Asset Management, L.P. | 1,183,888 | $3.10M | 0.01% | +350,555+42.1% | Added |
| FMR LLC | 1,574,826 | $4.13M | 0.00% | −971,835−38.2% | Reduced |
| OrbiMed Advisors LLC | 3,099,265 | $8.12M | 0.16% | 00.0% | Unchanged |
| Caas Capital Management LP | 0 | $0 | 0.00% | −45,831−100.0% | Sold out |